Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	15,787	17,636	-	-	-	-	Upgrade
Enterprise Value	35,557	32,313	-	-	-	-	Upgrade
Last Close Price	222.00	248.00	-	-	-	-	Upgrade
PE Ratio	6.27	7.89	-	-	-	-	Upgrade
PS Ratio	0.15	0.17	-	-	-	-	Upgrade
PB Ratio	1.09	1.22	-	-	-	-	Upgrade
P/TBV Ratio	1.35	1.50	-	-	-	-	Upgrade
P/FCF Ratio	96.85	108.20	-	-	-	-	Upgrade
P/OCF Ratio	6.31	7.05	-	-	-	-	Upgrade
EV/Sales Ratio	0.34	0.31	-	-	-	-	Upgrade
EV/EBITDA Ratio	5.57	5.05	-	-	-	-	Upgrade
EV/EBIT Ratio	10.46	9.47	-	-	-	-	Upgrade
EV/FCF Ratio	218.14	198.24	-	-	-	-	Upgrade
Debt / Equity Ratio	1.79	1.79	2.46	2.98	9.02	6.76	Upgrade
Debt / EBITDA Ratio	4.06	4.06	-	-	-	166.18	Upgrade
Debt / FCF Ratio	159.34	159.34	-	-	-	-	Upgrade
Asset Turnover	1.79	1.79	1.78	-	0.02	0.03	Upgrade
Inventory Turnover	21.57	21.57	20.62	-	-	-	Upgrade
Quick Ratio	0.45	0.45	0.34	0.26	0.15	0.14	Upgrade
Current Ratio	0.74	0.74	0.61	0.58	0.22	0.24	Upgrade
Return on Equity (ROE)	18.30%	18.30%	8.90%	-	-29.78%	-28.34%	Upgrade
Return on Assets (ROA)	3.68%	3.68%	2.74%	-	-0.13%	0.23%	Upgrade
Return on Capital (ROIC)	5.54%	5.54%	4.06%	-	-0.13%	0.23%	Upgrade
Return on Capital Employed (ROCE)	8.90%	8.90%	7.10%	1.50%	-	0.50%	Upgrade
Earnings Yield	14.15%	13.00%	-	-	-	-	Upgrade
FCF Yield	1.03%	0.92%	-	-	-	-	Upgrade
Dividend Yield	2.28%	1.21%	-	-	-	-	Upgrade
Payout Ratio	10.38%	10.38%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-	-5.19%	-0.04%	-	-	-	Upgrade
Total Shareholder Return	2.28%	-3.98%	-0.04%	-	-	-	Upgrade

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.